デフォルト表紙
市場調査レポート
商品コード
1435477

経口避妊薬の世界市場レポート 2024

Oral Contraceptive Pills Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
経口避妊薬の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

経口避妊薬の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には14.8%の年間複合成長率(CAGR)で471億5,000万米ドルに成長すると予想されます。予測期間で予想される成長は、人口の増加、女性のエンパワーメント、ヘルスケア支出の増加、ヘルスケアインフラの進歩、製品ポートフォリオの拡大に関連しています。この期間に予想される主な動向には、副作用やホルモン分泌の乱れを最小限に抑えることへの注目、非ホルモン性避妊薬や天然避妊薬の出現、継続的でオーダーメイドの避妊レジメンへのシフト、意識の高まり、教育イニシアティブ、女性のエンパワーメントと避妊選択への関与の増加が含まれます。

予想される望まない妊娠の増加は、今後数年間で経口避妊薬市場の成長の原動力となると予想されます。カリフォルニア大学が実施した研究で示されたように、計画や望まれていない妊娠を特徴とする予期せぬ妊娠は、女性に1年間の経口避妊薬の処方を提供すると、望まない妊娠と中絶の割合が大幅に減少することが示されています。、サンフランシスコ(UCSF)。世界保健機関(WHO)によると、毎年世界中で約7,400万人の低中所得経済圏の女性が予期せぬ妊娠を経験しています。 WHOの調査では、4,794人の女性が避妊薬の使用を中止した後に望まない妊娠をしたことが浮き彫りになった。したがって、予期せぬ妊娠を防ぐことが不可欠であることが、経口避妊薬市場の成長を促進する重要な要素となります。

ヘルスケア費の増加傾向により、予見可能な将来、経口避妊薬市場の拡大が促進される見込みです。ヘルスケア支出とは、特定の期間内にヘルスケアサービスと製品に割り当てられた財源を含む総リソースを指します。ヘルスケア費の増加は全体的なヘルスケアアクセスの向上に貢献し、家族計画サービス、相談、手頃な価格の処方箋へのアクセスの向上を通じて経口避妊薬の採用を促進し、それによって市場の成長を刺激します。たとえば、メディケア・メディケイド・サービスセンターが2022年3月に発表した2021~2030年の国民医療支出(NHE)報告書によると、国民医療支出は2021年から2030年にかけて毎年平均5.1%増加し、ほぼ100万米ドルに達すると予測されています。 6兆8,000億米ドル。また、レポートでは、2021年から2030年にかけてメディケア支出が年間7.2%増加し、メディケイド支出が年間5.6%増加すると予測しています。その結果、ヘルスケア支出の増大が経口避妊薬市場の成長を推進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の経口避妊薬市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 組み合わせ
  • プロゲスチンのみ
  • その他のタイプ
  • 世界の経口避妊薬市場、カテゴリー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ジェネリック
  • ブランド
  • 世界の経口避妊薬市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • クリニック
  • オンラインチャンネル
  • パブリックチャンネルとNGO
  • その他の流通チャネル

第7章 地域および国の分析

  • 世界の経口避妊薬市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の経口避妊薬市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 経口避妊薬市場の競合情勢
  • 経口避妊薬市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • Merck &Co. Inc.
    • Novartis AG
    • AbbVie Inc.

第31章 その他の大手および革新的な企業

  • Bayer AG
  • Sanofi SA
  • GlaxoSmithKline plc
  • Zydus Lifesciences Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Church &Dwight Co Inc.
  • Aurobindo Pharma Limited
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Ferring BV
  • Amneal Pharmaceuticals LLC
  • Lupin Pharmaceuticals Inc.
  • Vardhaman Lifecare Pvt. Ltd.
  • Glenmark Pharmaceuticals

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r15197

Oral contraceptive pills are tablets designed for contraception, containing hormones that inhibit the release of eggs from the ovaries. Typically, these pills contain both progestin and estrogen. Commonly known as birth control pills, they consist of hormones that prevent the ovaries from releasing eggs. The majority of oral contraceptives incorporate both estrogen and progestin.

The market for oral contraceptive pills is categorized by type into combination, progestin-only, and others; by category into generic and branded; and by distribution channel into hospital pharmacy, retail pharmacy, clinics, online channels, public channels and NGOs, among others.

The oral contraceptive pills market research report is one of a series of new reports from The Business Research Company that provides oral contraceptive pills market statistics, including oral contraceptive pills industry global market size, regional shares, competitors with an oral contraceptive pills market share, detailed oral contraceptive pills market segments, market trends and opportunities, and any further data you may need to thrive in the oral contraceptive pills industry. This oral contraceptive pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral contraceptive pills market size has grown rapidly in recent years. It will grow from $23.66 billion in 2023 to $27.12 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth observed in the historical period can be attributed to heightened awareness, escalating concerns about women's health, government initiatives, shifting lifestyles, and the expansion of the market.

The oral contraceptive pills market size is expected to see rapid growth in the next few years. It will grow to $47.15 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The anticipated growth in the forecast period is linked to a growing population, women's empowerment, increased healthcare expenditure, advancements in healthcare infrastructure, and the expansion of product portfolios. Key trends expected during this period involve a focus on minimizing side effects and hormonal disruption, the emergence of non-hormonal and natural contraceptive alternatives, a shift towards continuous and tailored contraceptive regimens, heightened awareness, and education initiatives, as well as an increase in female empowerment and involvement in contraceptive choices.

The anticipated rise in unintended pregnancies is expected to be a driving force behind the growth of the oral contraceptive pills market in the upcoming years. Unintended pregnancies, characterized by pregnancies that are not planned or desired, have shown a substantial decrease in rates of unwanted pregnancy and abortion when women are provided with a one-year prescription of oral contraceptives, as indicated by a study conducted by the University of California, San Francisco (UCSF). According to the World Health Organization (WHO), approximately 74 million women in low-middle-income economies globally experience unplanned pregnancies each year. The WHO's research highlights that 4,794 women had unintended pregnancies after discontinuing the use of contraceptives. Thus, the imperative to prevent unintended pregnancies is a key factor driving the growth of the oral contraceptive pills market.

The upward trajectory of healthcare expenditure is poised to fuel the expansion of the oral contraceptive pill market in the foreseeable future. Healthcare expenditure refers to the total resources, including financial resources, allocated to healthcare services and products within a specific period. The increasing healthcare expenditure contributes to enhanced overall healthcare accessibility, facilitating a greater adoption of oral contraceptive pills through improved access to family planning services, consultations, and affordable prescriptions, thereby stimulating market growth. For example, according to the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services in March 2022, national health spending is projected to increase by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. The report also anticipates a 7.2% annual rise in Medicare spending and a 5.6% annual increase in Medicaid spending from 2021 to 2030. Consequently, the escalating healthcare expenditures are propelling the growth of the oral contraceptive pills market.

Key institutes and companies in the oral contraceptive pill sector are actively engaged in developing innovative solutions, exemplified by HRA Pharma, a France-based healthcare company. In July 2022, HRA Pharma introduced Opill, an over-the-counter birth control pill, and applied for approval from the Food and Drug Administration in the United States. Opill, a progestin-based contraceptive, aims to provide easy access to contraception without unnecessary obstacles.

Prominent companies in the oral contraceptive pill market are also investing in innovative products, including progestin-only oral contraceptives, to cater to a broader customer base, increase sales, and boost revenue. Progestin-only oral contraceptives contain only a synthetic form of the hormone progestin. Perrigo Company PLC, an Ireland-based manufacturer of oral contraceptive pills, secured U.S. Food and Drug Administration (FDA) approval for Opill in July 2023. Opill, the first over-the-counter birth control pill in the United States, not only offers effective pregnancy prevention but also revolutionizes contraception access by being available without a prescription. This development underscores Perrigo's commitment to transformative solutions that enhance lives and exemplifies its dedication to pioneering impactful innovations in healthcare.

In April 2023, Marksans Pharma, an India-based pharmaceutical company, completed the acquisition of Teva Pharmaceutical Industries Ltd.'s manufacturing facility for an undisclosed amount. This acquisition provides Marksans with ownership of a 47,597-square-meter facility, effectively doubling its current production capacity in India to 8 billion units per year. The expanded facility will be utilized for manufacturing various pharmaceutical products, including tablets, hard and soft gel capsules, ointments, liquids, and creams, with Teva Pharmaceutical Industries Ltd. being known for its manufacturing of oral contraceptive pills.

Major companies operating in the oral contraceptive pills market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Abbvie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline PLC, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co Inc., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Ferring B.V, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Vardhaman Lifecare Pvt. Ltd., Glenmark Pharmaceuticals, Piramal Enterprises Ltd., Mankind Pharma Ltd., Sopharma AD, Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Syzygy Healthcare, V Care Pharma, Actavis PLC, Mylan N.V.

North America was the largest region in the oral contraceptive pills market in 2023. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral contraceptive pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The oral contraceptive pills market consists of sales of combined estrogen-progesterone, progesterone-only, and continuous or extended use pill. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Contraceptive Pills Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral contraceptive pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral contraceptive pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral contraceptive pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Combination; Progestin Only; Other Types
  • 2) By Category: Generic; Branded
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channel; Public Channel And NGO; Other Distribution Channels
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Novartis AG; Abbvie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oral Contraceptive Pills Market Characteristics

3. Oral Contraceptive Pills Market Trends And Strategies

4. Oral Contraceptive Pills Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Oral Contraceptive Pills Market Size and Growth

  • 5.1. Global Oral Contraceptive Pills Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Oral Contraceptive Pills Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Oral Contraceptive Pills Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oral Contraceptive Pills Market Segmentation

  • 6.1. Global Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Combination
  • Progestin Only
  • Other Types
  • 6.2. Global Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Generic
  • Branded
  • 6.3. Global Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channel
  • Public Channel And NGO
  • Other Distribution Channels

7. Oral Contraceptive Pills Market Regional And Country Analysis

  • 7.1. Global Oral Contraceptive Pills Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Oral Contraceptive Pills Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oral Contraceptive Pills Market

  • 8.1. Asia-Pacific Oral Contraceptive Pills Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oral Contraceptive Pills Market

  • 9.1. China Oral Contraceptive Pills Market Overview
  • 9.2. China Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oral Contraceptive Pills Market

  • 10.1. India Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oral Contraceptive Pills Market

  • 11.1. Japan Oral Contraceptive Pills Market Overview
  • 11.2. Japan Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oral Contraceptive Pills Market

  • 12.1. Australia Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oral Contraceptive Pills Market

  • 13.1. Indonesia Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oral Contraceptive Pills Market

  • 14.1. South Korea Oral Contraceptive Pills Market Overview
  • 14.2. South Korea Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oral Contraceptive Pills Market

  • 15.1. Western Europe Oral Contraceptive Pills Market Overview
  • 15.2. Western Europe Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oral Contraceptive Pills Market

  • 16.1. UK Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oral Contraceptive Pills Market

  • 17.1. Germany Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oral Contraceptive Pills Market

  • 18.1. France Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oral Contraceptive Pills Market

  • 19.1. Italy Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oral Contraceptive Pills Market

  • 20.1. Spain Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oral Contraceptive Pills Market

  • 21.1. Eastern Europe Oral Contraceptive Pills Market Overview
  • 21.2. Eastern Europe Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oral Contraceptive Pills Market

  • 22.1. Russia Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oral Contraceptive Pills Market

  • 23.1. North America Oral Contraceptive Pills Market Overview
  • 23.2. North America Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oral Contraceptive Pills Market

  • 24.1. USA Oral Contraceptive Pills Market Overview
  • 24.2. USA Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oral Contraceptive Pills Market

  • 25.1. Canada Oral Contraceptive Pills Market Overview
  • 25.2. Canada Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oral Contraceptive Pills Market

  • 26.1. South America Oral Contraceptive Pills Market Overview
  • 26.2. South America Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oral Contraceptive Pills Market

  • 27.1. Brazil Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oral Contraceptive Pills Market

  • 28.1. Middle East Oral Contraceptive Pills Market Overview
  • 28.2. Middle East Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oral Contraceptive Pills Market

  • 29.1. Africa Oral Contraceptive Pills Market Overview
  • 29.2. Africa Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oral Contraceptive Pills Market Competitive Landscape And Company Profiles

  • 30.1. Oral Contraceptive Pills Market Competitive Landscape
  • 30.2. Oral Contraceptive Pills Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Oral Contraceptive Pills Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Sanofi S.A.
  • 31.3. GlaxoSmithKline plc
  • 31.4. Zydus Lifesciences Ltd.
  • 31.5. Sun Pharmaceutical Industries Ltd.
  • 31.6. Teva Pharmaceutical Industries Ltd.
  • 31.7. Church & Dwight Co Inc.
  • 31.8. Aurobindo Pharma Limited
  • 31.9. Cipla Inc.
  • 31.10. Dr. Reddy's Laboratories Ltd.
  • 31.11. Ferring B.V
  • 31.12. Amneal Pharmaceuticals LLC
  • 31.13. Lupin Pharmaceuticals Inc.
  • 31.14. Vardhaman Lifecare Pvt. Ltd.
  • 31.15. Glenmark Pharmaceuticals

32. Global Oral Contraceptive Pills Market Competitive Benchmarking

33. Global Oral Contraceptive Pills Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Oral Contraceptive Pills Market

35. Oral Contraceptive Pills Market Future Outlook and Potential Analysis

  • 35.1 Oral Contraceptive Pills Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Oral Contraceptive Pills Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Oral Contraceptive Pills Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer